Related Experiment Video
Updated: May 18, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Resting heart rate and outcomes in patients with cardiovascular disease: where do we currently stand?
Ian B A Menown1, Simon Davies, Sandeep Gupta
1Craigavon Cardiac Centre, Craigavon, UK. ian.menown@southerntrust.hscni.net
Insights
Elevated resting heart rate increases cardiovascular risk. Reducing heart rate through lifestyle or medication may lower this risk, especially for those with heart disease or heart failure.
Area of Science:
- Cardiology
- Clinical Epidemiology
- Pharmacology
Background:
- Large epidemiological studies link elevated heart rate to increased cardiovascular and all-cause mortality in hypertensive and cardiovascular disease patients.
- Beta-blockers and other heart rate-lowering agents show benefits in acute myocardial infarction and congestive heart failure, potentially due to heart rate reduction.
- Admission heart rate is an independent risk factor in clinical outcome prediction models like the Global Registry of Acute Coronary Events (GRACE) score.
Purpose of the Study:
- To critically review the epidemiology of heart rate and cardiovascular risk.
- To explore potential mechanisms linking elevated resting heart rate to adverse outcomes.
- To evaluate clinical trial outcomes of pharmacological heart rate reduction.
Main Methods:
- Review of epidemiological data.
- Analysis of clinical trial outcomes.
- Evaluation of pharmacological interventions.
Main Results:
- Prospective randomized data indicate that reducing resting heart rate in patients with significant coronary heart disease or heart failure (resting heart rate >70 bpm) may decrease cardiovascular risk.
- Observational data and randomized trial evidence support the role of heart rate reduction in cardiovascular risk management.
Conclusions:
- Intervention to lower resting heart rate (target >70 bpm) is suggested for patients with coronary heart disease or heart failure.
- Reduction of elevated resting heart rate via lifestyle modifications and/or pharmacological therapy should be considered a key component of secondary prevention in cardiovascular disease patients.
Background:
Data from large epidemiological studies suggest that elevated heart rate is independently associated with cardiovascular and all-cause mortality in patients with hypertension and in those with established cardiovascular disease. Clinical trial findings also suggest that the favorable effects of beta-blockers and other heart rate-lowering agents in patients with acute myocardial infarction and congestive heart failure may be, at least in part, due to their heart rate-lowering effects. Contemporary clinical outcome prediction models such as the Global Registry of Acute Coronary Events (GRACE) score include admission heart rate as an independent risk factor.
Aims:
This article critically reviews the key epidemiology concerning heart rate and cardiovascular risk, potential mechanisms through which an elevated resting heart rate may be disadvantageous and evaluates clinical trial outcomes associated with pharmacological reduction in resting heart rate.
Conclusions:
Prospective randomised data from patients with significant coronary heart disease or heart failure suggest that intervention to reduce heart rate in those with a resting heart rate >70 bpm may reduce cardiovascular risk. Given the established observational data and randomised trial evidence, it now appears appropriate to include reduction of elevated resting heart rate by lifestyle +/- pharmacological therapy as part of a secondary prevention strategy in patients with cardiovascular disease.
Related Concept Videos
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Exercise and Cardiac Output
Sustained exercise increases the muscles' oxygen demand, which can be met...
Heart Failure IV: Classification and Diagnostic Evaluation
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Factors Influencing Heart Rate
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
